Lumina Specialist Hospital – Business Plan
Investment-grade business plan for Lumina Health Holdings (Pty) Ltd — an R900-million raise to build a 120-bed specialist hospital in South Africa anchored by interventional cardiology, modern theatres and an ICU, reaching R666 million revenue by Year 5 and R784 million by Year 7 at a 21% EBITDA margin, a 17.2% equity IRR, a 3.0× MOIC and an R141-million NPV.
Confidential Business Plan
Lumina Specialist Hospital
A 120-bed specialist hospital for South Africa — anchored by interventional cardiology and five anchor service lines, with modern theatres and an intensive-care unit, developed and operated by Lumina Health Holdings — structured as an investment-grade R900-million opportunity for senior lenders, development-finance institutions and equity investors.
South Africa’s private healthcare market is large and structurally resilient, with around 9.17 million medical-scheme beneficiaries and persistent demand for high-acuity specialist capacity that the incumbent groups do not fully meet. Lumina Specialist Hospital captures this with a purpose-built, 120-bed specialist facility — interventional cardiology, modern theatres and an intensive-care unit across five anchor service lines — with EBITDA positive from the first year of operation and an EBITDA margin reaching 21%. An R900-million raise (senior debt, development finance and equity) takes revenue to R666 million by Year 5 and R784 million by Year 7, breaking even in Year 5 and delivering a 16.8% project IRR, a 17.2% equity IRR, a 3.0× equity MOIC at a Year-7 exit and a positive R141-million NPV at a 13.5% WACC.
Plan Contents
This investor-grade business plan is organised into the sections below. Each section is a dedicated page — select any to explore the full detail.
- 1Executive Summary
- 2Company Overview
- 3Industry & Market Analysis
- 4Competitive Analysis
- 5Services & Clinical Model
- 6Business Model & Revenue Engine
- 7Marketing & Patient Acquisition
- 8Operations Plan
- 9Management & Governance
- 10Implementation Roadmap
- 11Risk Register & Mitigation
- 12ESG, Transformation & Development Impact
- 13Financial Plan
- 14Funding Strategy & Structure
- 15Exit Strategy
- 16Conclusion
- 17Appendices
Important Notice & Disclaimer
This document (the “Business Plan”) has been prepared by Lumina
Health Holdings (Pty) Ltd (the “Company” or “Sponsor”) solely to provide
preliminary information to a limited number of prospective lenders,
development finance institutions and equity investors in connection with
a proposed investment in Lumina Specialist Hospital (the “Project”). It
is provided on a strictly private and confidential basis and may not be
reproduced, distributed or disclosed, in whole or in part, to any other
person without the prior written consent of the Company.
This Business Plan does not constitute an offer, invitation or
solicitation to subscribe for or purchase any securities, debt
instruments or other financial products, and shall not form the basis
of, or be relied upon in connection with, any contract or investment
decision. Any such offer would be made only pursuant to definitive
transaction documents and following the recipient’s own due
diligence.
The financial projections, market estimates and operational
assumptions contained herein are forward-looking by nature. They reflect
numerous assumptions regarding future events and circumstances that are
inherently uncertain and subject to material change. Actual results may
differ materially from those projected. Greenfield hospital developments
are capital-intensive, take time to reach stabilised occupancy, and are
exposed to construction, clinical, regulatory and financing risks.
Nothing in this document should be construed as a guarantee or assurance
of future performance.
No representation or warranty, express or implied, is given by the
Company, its directors, advisers or agents as to the accuracy or
completeness of the information contained in this Business Plan, and no
liability is accepted for any loss arising from its use. Prospective
investors and lenders should not treat the contents as advice relating
to legal, taxation, accounting, regulatory or investment matters and are
strongly advised to conduct independent due diligence and to consult
their own professional advisers before making any decision.
This Business Plan has been prepared on an “honest-analyst” basis.
Where the Sponsor’s headline ambitions are reflected, the financial
model independently re-derives profitability on conservative terms (full
depreciation, full interest, 27% corporate tax). Assumptions the authors
regard as aggressive — including the occupancy ramp, the thin break-even
margin of safety, sub-1.0x debt-service cover in the ramp and
early-amortisation years, and the dependence of equity returns on a
Year-7 trade sale — are flagged explicitly in gold callout boxes
throughout. Independent commercial, clinical and technical due diligence
is recommended before any external circulation or commitment.
Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Lumina Health Holdings (Pty) Ltd.